ArticleFrontiers in oncology2022

Identify optimal HAP series scores for unresectable HCC patients undergoing TACE plus sorafenib: A Chinese multicenter observational study.

Yejing Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.